Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$28.19 - $46.6 $19,733 - $32,620
700 Added 10.14%
7,600 $281,000
Q4 2021

Feb 15, 2022

SELL
$41.2 - $73.6 $531,480 - $949,439
-12,900 Reduced 65.15%
6,900 $314,000
Q3 2021

Nov 16, 2021

BUY
$59.15 - $91.99 $786,695 - $1.22 Million
13,300 Added 204.62%
19,800 $1.26 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $201,664 - $304,352
-3,200 Reduced 32.99%
6,500 $595,000
Q1 2021

May 18, 2021

BUY
$57.62 - $95.6 $149,812 - $248,559
2,600 Added 36.62%
9,700 $660,000
Q4 2020

Feb 17, 2021

SELL
$41.43 - $77.09 $41,430 - $77,090
-1,000 Reduced 12.35%
7,100 $514,000
Q2 2020

Aug 17, 2020

BUY
$18.95 - $35.43 $153,495 - $286,983
8,100 New
8,100 $287,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.19B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.